Kuros Biosciences Ltd.
Develops biologic technologies for tissue repair and bone regeneration.
KURN | SW
Overview
Corporate Details
- ISIN(s):
- CH0325814116
- LEI:
- 5299006U5POB2AVTT709
- Country:
- Switzerland
- Address:
- Wagisstraße 25, 8952 Schlieren
- Website:
- https://kurosbio.com/
- Sector:
- Manufacturing
Description
Kuros Biosciences is a life sciences company that discovers, develops, and delivers innovative biologic technologies focused on tissue repair and bone regeneration. The company's mission is to address unmet clinical needs for safer, faster, and more predictable bone healing. Its primary commercial product is MagnetOs, an advanced bone graft designed to enhance bone formation. The efficacy of MagnetOs is supported by a comprehensive global research program, "Project Fusion," which includes scientific, pre-clinical, and Level I human clinical studies. Kuros Biosciences serves surgeons and patients across multiple medical fields, including spine, extremities, trauma, and oncology, leveraging deep scientific expertise and collaboration with leading clinical experts.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2014-04-14 07:00 |
Cytos Biotechnology Ltd (SIX:CYTN) today published the topline results of the g…
|
English | 7.0 KB | ||
| 2014-04-03 15:14 |
Annual Shareholders' Meeting of Cytos Biotechnology Ltd: Shareholders approved …
|
English | 4.9 KB | ||
| 2014-03-31 07:00 |
Cytos Biotechnology Ltd announces amendment of convertible loan notes agreement
|
English | 6.3 KB | ||
| 2014-03-13 07:00 |
Cytos Biotechnology Ltd invites to the Annual Shareholders' Meeting in April 20…
|
English | 4.8 KB | ||
| 2014-02-13 07:00 |
Cytos Biotechnology Ltd announces full year 2013 financial results
|
English | 8.8 KB | ||
| 2014-01-29 07:00 |
Cytos Biotechnology Ltd: Singapore's first influenza vaccine demonstrates favou…
|
English | 12.0 KB | ||
| 2013-12-30 13:35 |
Cytos Biotechnology Ltd - Extraordinary Shareholders' Meeting - All Resolutions…
|
English | 4.9 KB | ||
| 2013-12-04 07:00 |
Cytos Biotechnology Ltd invites to an Extraordinary Shareholders' Meeting in De…
|
English | 10.4 KB | ||
| 2013-11-18 07:00 |
Cytos Biotechnology Ltd - Rights offering oversubscribed - CHF 24.3 million rai…
|
English | 12.1 KB | ||
| 2013-11-05 07:00 |
Cytos Biotechnology Ltd announces terms for capital increase
|
English | 12.4 KB | ||
| 2013-11-04 12:29 |
Extraordinary Shareholders' Meeting of Cytos Biotechnology Ltd: Shareholders ap…
|
English | 4.9 KB | ||
| 2013-10-31 07:00 |
Cytos Biotechnology Ltd: Third Quarter Report 2013
|
English | 15.8 KB | ||
| 2013-10-21 07:00 |
Cytos Biotechnology Ltd announced the completion of patient enrolment of the on…
|
English | 7.9 KB | ||
| 2013-10-17 18:00 |
Cytos Biotechnology Ltd announces hosting of Investor & Analyst Day in NYC
|
English | 8.6 KB | ||
| 2013-10-10 07:00 |
Cytos Biotechnology Ltd announces financing transaction
|
English | 13.1 KB |
Automate Your Workflow. Get a real-time feed of all Kuros Biosciences Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kuros Biosciences Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kuros Biosciences Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-23 | N/A | Executive member | Sell | None | 1,264,800.00 CHF |
| 2025-04-17 | N/A | Executive member | Sell | None | 13,344.49 CHF |
| 2025-03-18 | N/A | Non-Executive member | Buy | None | 38,200.00 CHF |
| 2024-12-11 | N/A | Executive member | Sell | None | 4,702,500.00 CHF |
| 2024-11-15 | N/A | Non-Executive member | Buy | None | 925,210.00 CHF |
| 2024-11-14 | N/A | Non-Executive member | Sell | None | 592,000.00 CHF |
| 2024-11-12 | N/A | Executive member | Sell | None | 13,890.86 CHF |
| 2024-09-25 | N/A | Executive member | Sell | None | 8,226,000.00 CHF |
| 2024-09-25 | N/A | Non-Executive member | Sell | None | 3,656,000.00 CHF |
| 2024-09-24 | N/A | Non-Executive member | Buy | None | 223,720.00 CHF |
Peer Companies
